Live Breaking News & Updates on Takeda Will Work|Page 2
Stay updated with breaking news from Takeda will work. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Japanese drug giant Takeda has partnered with Indian vaccine maker Biological E (BE) to manufacture its Dengue vaccine. BE will increase its manufacturing capacity to up to 50 million doses a year, supporting Takeda s goal to produce 100 million doses annually by 2030. The collaboration leverages Takeda s existing facility in Germany and its partnership with IDT Biologika GmbH. ....
India Business News: Takeda and Biological E Limited have partnered to manufacture up to 50 million doses per year of the dengue vaccine QDENGA, with the goal of deliverin ....
HUTCHMED China (?HCM) announced marketing approval of ELUNATE, or fruquintinib by the Pharmacy and Poisons Board of Hong Kong for the treatment of adult patients with previously treated metastatic colorectal cancer. ....
Takeda (TAK) announced the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended the approval of HYQVIA in patients with chronic inflammatory demyelinating polyneuropathy as maintenance therapy after stabilization with intravenous immunoglobulin therapy. ....